What does PHAR WEST do?

PHAR WEST is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 1 April 2015, 1 establishment.

What is the address of PHAR WEST?

The registered office of PHAR WEST is located at Dorpsstraat 2, 8660 De Panne.

Is PHAR WEST still active?

Yes. According to the CBE (30 October 2026) PHAR WEST is active, legal situation “Normale toestand”, started on 1 April 2015.

Is PHAR WEST registered on Peppol?

Yes, PHAR WEST is registered on the Peppol network with ID 0208:0627814187.

What is the enterprise number of PHAR WEST?

The enterprise number of PHAR WEST is BE0627814187.

When was PHAR WEST founded?

PHAR WEST was founded on 1 April 2015.

Who are the directors of PHAR WEST?

According to the 2025 annual accounts, the directors of PHAR WEST are: Tine Wouters, Monica Van Steenberghe.

Is PHAR WEST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 April 2015; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHAR WEST make in 2025?

PHAR WEST posted a profit after taxes of € 123,340 in financial year 2025.

What is the revenue of PHAR WEST?

As a small company, PHAR WEST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 220,643.

How many employees does PHAR WEST have?

According to the 2025 annual accounts, PHAR WEST has 0 full-time equivalents (FTE).

Does PHAR WEST have a website?

Yes, PHAR WEST has a website at audopharma.be.

PHAR WEST (Private Limited) - De Panne - BE0627814187

Dossier PHAR WEST, printed on 30 October 2026 from databakkes.be/en/0627814187/phar-west. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 48 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHAR WEST from De Panne, company number BE0627814187, closed financial year 2025 with a result of € 123,340 after tax. For that financial year PHAR WEST recorded a gross margin of € 220,643 and equity of € 903,535. Compared with financial year 2024, the result moved from € 117,575 to € 123,340. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 903,535

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 123,340

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 80,305

▲ 145% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 753,535.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 535,264

▼ 14% vs 2024

€ 86,212 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 1,128

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,221

▲ 26% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 172,933 Gross margin 2022: € 172,933 First fiscal year in the series	€ 203,459 Gross margin 2023: € 203,459 ▲ 18% vs 2022 (€ 172,933) Favourable step	€ 210,520 Gross margin 2024: € 210,520 ▲ 3% vs 2023 (€ 203,459) Favourable step	€ 220,643 Gross margin 2025: € 220,643 ▲ 5% vs 2024 (€ 210,520) Favourable step	▲ 5%
Profit after taxes	€ 90,489 Profit after taxes 2022: € 90,489 First fiscal year in the series	€ 112,680 Profit after taxes 2023: € 112,680 ▲ 25% vs 2022 (€ 90,489) Favourable step	€ 117,575 Profit after taxes 2024: € 117,575 ▲ 4% vs 2023 (€ 112,680) Favourable step	€ 123,340 Profit after taxes 2025: € 123,340 ▲ 5% vs 2024 (€ 117,575) Favourable step	▲ 5%
Equity	€ 549,940 Equity 2022: € 549,940 First fiscal year in the series	€ 662,620 Equity 2023: € 662,620 ▲ 20% vs 2022 (€ 549,940) Favourable step	€ 780,195 Equity 2024: € 780,195 ▲ 18% vs 2023 (€ 662,620) Favourable step	€ 903,535 Equity 2025: € 903,535 ▲ 16% vs 2024 (€ 780,195) Favourable step	▲ 16%
Total debts	€ 1,026,420 Total debts 2022: € 1,026,420 First fiscal year in the series	€ 949,589 Total debts 2023: € 949,589 ▼ 7% vs 2022 (€ 1,026,420) Favourable step	€ 855,499 Total debts 2024: € 855,499 ▼ 10% vs 2023 (€ 949,589) Favourable step	€ 768,803 Total debts 2025: € 768,803 ▼ 10% vs 2024 (€ 855,499) Favourable step	▼ 10%
Cash	€ 71,588 Cash 2022: € 71,588 First fiscal year in the series	€ 146,272 Cash 2023: € 146,272 ▲ 104% vs 2022 (€ 71,588) Favourable step	€ 32,825 Cash 2024: € 32,825 ▼ 78% vs 2023 (€ 146,272) Unfavourable step	€ 80,305 Cash 2025: € 80,305 ▲ 145% vs 2024 (€ 32,825) Favourable step	▲ 145%
Land & buildings	€ 492,305 Land & buildings 2022: € 492,305 First fiscal year in the series	€ 456,664 Land & buildings 2023: € 456,664 ▼ 7% vs 2022 (€ 492,305) Unchanged	€ 422,448 Land & buildings 2024: € 422,448 ▼ 7% vs 2023 (€ 456,664) Unchanged	€ 388,504 Land & buildings 2025: € 388,504 ▼ 8% vs 2024 (€ 422,448) Unchanged	▼ 8%
Retained profit	€ 399,940 Retained profit 2022: € 399,940 First fiscal year in the series	€ 512,620 Retained profit 2023: € 512,620 ▲ 28% vs 2022 (€ 399,940) Favourable step	€ 630,195 Retained profit 2024: € 630,195 ▲ 23% vs 2023 (€ 512,620) Favourable step	€ 753,535 Retained profit 2025: € 753,535 ▲ 20% vs 2024 (€ 630,195) Favourable step	▲ 20%
Bank debt	€ 793,900 Bank debt 2022: € 793,900 First fiscal year in the series	€ 707,688 Bank debt 2023: € 707,688 ▼ 11% vs 2022 (€ 793,900) Favourable step	€ 621,476 Bank debt 2024: € 621,476 ▼ 12% vs 2023 (€ 707,688) Favourable step	€ 535,264 Bank debt 2025: € 535,264 ▼ 14% vs 2024 (€ 621,476) Favourable step	▼ 14%
Balance sheet total	€ 1,576,360 Balance sheet total 2022: € 1,576,360 First fiscal year in the series	€ 1,612,208 Balance sheet total 2023: € 1,612,208 ▲ 2% vs 2022 (€ 1,576,360) Unchanged	€ 1,635,694 Balance sheet total 2024: € 1,635,694 ▲ 1% vs 2023 (€ 1,612,208) Unchanged	€ 1,672,338 Balance sheet total 2025: € 1,672,338 ▲ 2% vs 2024 (€ 1,635,694) Unchanged	▲ 2%

Key figures of PHAR WEST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHAR WEST?

What happened at PHAR WEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 123,340 (▲ 5% vs 2024). Source: NBB ↗
Apr 1, 2015 New establishment in De Panne. KBO
Apr 1, 2015 Start of the company according to the CBE. KBO

In short

From € 90,489 profit in 2022 to € 123,340 profit in 2025.

Paid € 129,951 in corporate taxes since 2022.

Best year ever: 2025, with € 123,340 profit.

Original PDFs at the National Bank ↗

Management

Tine Wouters

Monica Van Steenberghe

PHAR WEST

Audopharma 99.9%

Behind PHAR WEST are Tine Wouters and Monica Van Steenberghe. It owns 99.9% of Audopharma itself.

Directors

According to the 2025 annual accounts

Tine Wouters

Director

Monica Van Steenberghe

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 2

8660 De Panne

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

AUDOPHARMA same network

€ 114,780 gross margin · 2025

Groep De Medicijnnatie

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS audopharma.be

About

Technologies

AWS S3BootstrapFont AwesomeGoogle AnalyticsGoogle FontsMailchimpjQueryreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

DSTNY-BACKBONE International Backbone, BE

Website info

HTTPS Ja

Languages EN

Features

Newsletter Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0627.814.187

VAT number

BE 0627.814.187

Registered office

Dorpsstraat 2, 8660 De Panne

Names & denominations

PHAR WEST

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 April 2015

Peppol

Active · Active since 6 Nov 2025

Contact

audopharma.be

Activities · NACE

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

PHAR WEST

Warning lights

Financials

What happened to PHAR WEST?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions